dfdsfdsfd

Prof. Valérie D’Acremont is a physician, epidemiologist and global health expert specialized in infectious and tropical diseases, head of Digital and Global health at Unisanté, University of Lausanne, and research group leader at SwissTPH, Basel. She also worked as Febrile illness expert at WHO, Geneva. She is presently leading large operational research projects aimed at decreasing morbidity and mortality in patients living in resource-limited countries or coming back to Europe from the tropics, using electronic clinical decision algorithms connected to biosensors and point-of-care tests. The aim of these projects is also to enhance disease surveillance and outbreak detection, while preserving essential resources, such as antimicrobials, and limiting the carbon footprint and impact on the environment. She is presently involved in the daily operational management of the COVID-19 epidemic at primary care and community level in collaboration with the Canton de Vaud health authorities. She designed several urgent applied scientific projects aimed at finding the best strategies to monitor and prevent the spread of SARS-CoV-2 in Switzerland, in collaboration with FOPH and SSPH+.

Ron Dagan is Distinguished Professor of Pediatrics and Infectious Diseases at the Ben-Gurion University of the Negev, Beer-Sheva, Israel. He founded the Pediatric Infectious Disease Unit at Soroka University Medical Center in Beer-Sheva and served as its director from 1987 to 2014. Prof. Dagan has served on the National Advisory Committee on Infectious Diseases and Immunization since 1991 and has been a member of the Nationwide Working Group on Corona Vaccines since 2020. He has earned international recognition for his research, focusing largely on the development on vaccine-preventable diseases.

Dana Danino graduated from the Rappaport Faculty of Medicine, Institute of Technology, Haifa, in 2006, and specialized in Pediatrics in the Sourasky Medical Center, Tel-Aviv, Israel. She has worked as a senior pediatrician in the Soroka University Medical Center, Beer-Sheva, Israel, since 2014 and in 2017 completed her Fellowship in Infectious Diseases, with honors, at the same hospital. In 2019 she graduated the Host Defense ID Fellowship program in the Pediatric Infectious Diseases, Nationwide Children's Hospital, Ohio, USA. Since 2017 she is a Lecturer at the Faculty of Health Sciences in Ben-Gurion University of the Negev. At the clinical level she is working as a consultant at the Department of Pediatrics of the same University hospital. Her current research / scientific interests focus on vaccine preventable infections and vaccination of children after hematopoietic stem cell transplant, antibiotic consumption in the community, pneumococcal infections and vaccines and the impact of COVID-19 pandemic on the burden of respiratory infections in children. Dana has contributed peer-reviewed articles publications and has presented her research work in numerous National and International congresses. Dana is Israel's young European Society of Pediatric Infectious Diseases representative, a member of Israeli Pediatric Society and the Israeli Infectious Diseases Society. Dana lives in Tel-Aviv with her husband and 3 children and enjoys running and biking.

Lara Danziger-Isakov, MD, MPH, practices pediatric infectious diseases at Cincinnati Children's Hospital Medical Center where she is Professor of Pediatrics at the University of Cincinnati. Dr. Danziger-Isakov earned her MD at Case Western Reserve University School of Medicine and complete her residency in Pediatrics at the Cleveland Clinic. She also completed a fellowship in Pediatric Infectious Diseases at Saint Louis Children's Hospital. Her clinical interests include pediatric infectious diseases, infections in transplant recipients, and infections in immunocompromised hosts. Her research interests include outcomes related to infection after pediatric transplantation with an emphasis prevention, diagnosis and treatment of infections in solid organ and hematopoietic stem cell transplant recipients. She leads several multi-centered clinical trials focused on cytomegalovirus, respiratory viruses and vaccination in this population. In addition, Dr. Danziger-Isakov participates in clinical trials to evaluate both new infectious disease therapies and new methods of detection for infectious diseases.

Ronald de Groot (1948, Rotterdam, the Netherlands) studied Medicine at the Erasmus University Rotterdam (MD, 197 ), followed by a residency in Gynecology/Obstetrics and Surgery as a preparation for a 2½ year period as Senior Medical Officer in St. Louis Hospital, Zonkwa, Nigeria. He subsequently did his pediatric residency (1979-1983) in the Sophia Children’s Hospital in Rotterdam under the supervision of Professor Henk Visser and became chief resident from 1983 to 1985. In 1985 he went to the United States, where he was accepted for a research fellowship (1985-1988) in paediatric infectious diseases at the University of Washington, Seattle, under the supervision of Professor Arnold Smith. In the summer of 1988 he returned to the Erasmus University in Rotterdam where he initiated a programme in Paediatric Infectious Diseases and Immunology in the Sophia Children’s Hospital. In 1991 he defended his PhD thesis entitled “Antibiotic Resistance in Haemophilus influenzae”. In 1998, Ronald became head of the PID training programme and Professor in Pediatric Infectious Diseases and Immunology in the Sophia Children’s Hospital/Erasmus University Medical Centre. During his tenure in Rotterdam he was involved in a large number of activities including a membership of the Board of Molecular Medicine (MOLMED), the largest research school in the Netherlands, treasurer of the Board of the Dutch Society of Infectious Diseases, secretary of Dutch Federation of Medical Societies and the director of a vaccine company, Vaxinostics, part of the Erasmus MC Holding. Ronald is one of the founding members of the Dutch Society of Paediatric Infectious Diseases as well as the Society’s first chairman, from 1994 – 1998. As an active member of ESPID since 1990,Ronald has been involved in many activities of the Society in the fields of research, teaching, education, training and organization of PID in Europe. May 1st 2005, he was appointed chair of the Department of Paediatrics of the University Medical Centre Nijmegen as well as Professor of Paediatrics at the Radboud University Nijmegen. Ronald’s research activities over the years have covered several themes including the study of respiratory tract infections, the molecular pathogenesis of infections by S. pneumoniae and Neisseria meningitidis, clinical and pharmacological studies in children with HIV, clinical and translational research in children with immunodeficiencies, vaccine studies and studies on viral host response interactions. Ronald is a member of a large number of national and international societies. He was chairman of the Pediatric Association of The Netherlands (1998 – 2004). He also was a member of the Health Council of the Netherlands(2000-2014) and the Dutch Central Committee on Research involving Human Subjects(2009-2017), both Crown appointments. He is the recipient of the 2008 Bill Marshall Award of ESPID. In 2011, he received the prestigious Edgar Doncker Prize for Paediatrics in recognition of his substantial contributions in the field of Paediatrics and in particular in paediatric infectious diseases and immunology nationally and internationally. From 2013 until 2016 Ronald was President of the European Society for Pediatric Infectious Diseases. Since 2015 is Ronald member of the Board of the World Society of Pediatric Infectious Diseases and also treasurer and chairman of the WSPID Foundation. Ronald is an honorary member of the Pediatric Infectious Diseases Society of America. Ronald is currently emeritus Professor of Pediatrics (since 2013) with an appointment until March 1 2021 at the Radboud University Medical Center in Nijmegen. He is still actively involved in a large number of international projects including a Horizon 2020 project “PERFORM” and an IMI project in which the Bill and Melinda Gates Foundation is involved, entitled PERISCOPE. Ronald has been thesis supervisor of more than 45 PhD students and is currently still actively involved in the thesis of 7 PhD students. He is (co)author of approximately 300 English language peer-reviewed papers, 50 national (Dutch) publications and numerous contributions to books. Ronald currently has a position as Professor emeritus in the Radboud University Medical Center. He is not involved any more in clinical activities . He is president of the foundation “Vaccinology Masterclass organizing postgraduate training in vaccinology, treasurer of the WSPID and involved in multiple charity organizations.

In 2014 I completed medical school at the Erasmus University Rotterdam. After gaining clinical experience in Pediatrics I started my PhD on the host response during Mycoplasma pneumoniae carriage and infection, which consists of several translational projects supervised by dr. Wendy Unger and prof. Annemarie van Rossum. In 2020 I started in the Erasmus MC - Sophia Children's Hospital residency program in Pediatrics.

Maria Isabel de Moraes-Pinto is an Associate Professor in Pediatric Infectious Diseases at the Department of Pediatrics of the Federal University of São Paulo since 2006. She graduated in Medicine from the University of São Paulo (1984), with Master in Pediatrics from the Federal University of São Paulo (1991), PhD in Pediatrics from the Federal University of São Paulo (1996) and postdoc in Pediatric Infectious Diseases from the Federal University of São Paulo (2010). She is Head of the Research Laboratory of Pediatric Infectious Diseases at the Federal University of Sao Paulo since 1998. She is a member of the Brazilian Group of Immunodeficiency, of the Brazilian Society of Pediatrics and of the European Society Pediatric Infectology Department (ESPID). She has published 90 papers.

Dr. Demers-Mathieu is the Senior Research Scientist in the Department of Neonatal Immunology at Medolac Laboratories. Her lab focuses on the impact of immune components (antibodies, immune cells, cytokines, and bioactive proteins) from human milk to protect newborns against infectious diseases. Her long-term goal is to identify the role that human milk immune components play in the infant’s guts to prevent necrotizing enterocolitis, viral and bacterial infections in premature infants. Her overall objective is to develop a new supplement of human milk antibodies to protect infants against infectious diseases and improve infant health outcomes.

Prof/Dr.ABBASSIA DEMMOUCHE has received his PhD in Djillaly Liabes University during the period of 2003-2015. Currently, she is working as researcher in Djillaly Liabes University. she is serving as an editorial member of several reputed journals like journal of pregnancy& expert Reviewers for journals like « international research in medical and pharmaceutical sciences », «international journal of tropical disease and healthy » . she is a memberin many International and National Medical Journals. He has authored many research articles and is an author on the subject of nutrition, anemia, pregnancy and hematology.